Literature DB >> 7609083

Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D.

N M Mattion1, P A Reilly, E Camposano, S L Wu, S J DiMichele, S T Ishizaka, S E Fantini, J C Crowley, C Weeks-Levy.   

Abstract

Recombinant polioviruses expressing antigens from rotavirus, herpes simplex virus type 2, and hepatitis B virus were generated. Fusion of the heterologous polypeptides to the amino terminus of the poliovirus polyprotein did not prevent myristylation of VP0, suggesting a novel mechanism of myristylation for these recombinant viruses. The effects of the parental genetic background, different foreign sequences, and different insert sizes on growth characteristics were compared. Both the size and the nature of the heterologous sequence appeared to be factors influencing the growth and stability of recombinant polioviruses. All of the recombinants showed a temperature-sensitive phenotype, regardless of the genetic background (attenuated or wild type) from which they were derived. Preliminary studies with transgenic mice carrying the poliovirus receptor gene are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609083      PMCID: PMC189333          DOI: 10.1128/JVI.69.8.5132-5137.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.

Authors:  J M Tatem; C Weeks-Levy; A Georgiu; S J DiMichele; E J Gorgacz; V R Racaniello; F R Cano; S J Mento
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 2.  Proteolytic processing of picornaviral polyprotein.

Authors:  A C Palmenberg
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

3.  Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus.

Authors:  C Weeks-Levy; J M Tatem; S J DiMichele; W Waterfield; A F Georgiu; S J Mento
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

4.  Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture.

Authors:  A J Macadam; G Ferguson; J Burlison; D Stone; R Skuce; J W Almond; P D Minor
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

5.  Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein.

Authors:  G Larralde; B G Li; A Z Kapikian; M Gorziglia
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

6.  Expression of rotavirus proteins encoded by alternative open reading frames of genome segment 11.

Authors:  N M Mattion; D B Mitchell; G W Both; M K Estes
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

7.  Cleavage of synthetic peptides by purified poliovirus 3C proteinase.

Authors:  P V Pallai; F Burkhardt; M Skoog; K Schreiner; P Bax; K A Cohen; G Hansen; D E Palladino; K S Harris; M J Nicklin
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

8.  Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy.

Authors:  B V Prasad; J W Burns; E Marietta; M K Estes; W Chiu
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

9.  Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice.

Authors:  R Ren; V R Racaniello
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more
  15 in total

1.  Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Authors:  N M Chapman; K S Kim; S Tracy; J Jackson; K Höfling; J S Leser; J Malone; P Kolbeck
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

3.  Viable polioviruses that encode 2A proteins with fluorescent protein tags.

Authors:  Natalya L Teterina; Eric A Levenson; Ellie Ehrenfeld
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

4.  Expression of brain-derived neurotrophic factor in the central nervous system of mice using a poliovirus-based vector.

Authors:  Qingmei Jia; Fengyi Liang; Seii Ohka; Akio Nomoto; Tsutomu Hashikawa
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

5.  Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors:  M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 6.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

7.  Foot-and-mouth disease virus 2A protease mediates cleavage in attenuated Sabin 3 poliovirus vectors engineered for delivery of foreign antigens.

Authors:  N M Mattion; E C Harnish; J C Crowley; P A Reilly
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Novel design architecture for genetic stability of recombinant poliovirus: the manipulation of G/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system.

Authors:  Sang-Gu Lee; Dae-You Kim; Byung-Hwa Hyun; Yong-Soo Bae
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein.

Authors:  Y Zhang; G G Kaplan
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.

Authors:  D C Porter; L R Melsen; R W Compans; C D Morrow
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.